Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.
2.

Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.

Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, Brookes R, Meyers NJ, Lehner T.

J Immunol. 1996 Sep 15;157(6):2521-7.

PMID:
8805653
3.

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT.

J Virol. 1997 Apr;71(4):3138-45.

4.

Mucosal immunization with DNA-liposome complexes.

Klavinskis LS, Gao L, Barnfield C, Lehner T, Parker S.

Vaccine. 1997 Jun;15(8):818-20.

PMID:
9234523
7.

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.

Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR.

J Immunol. 2002 Jul 1;169(1):566-74.

9.

Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.

Lehner T, Bergmeier LA, Tao L, Panagiotidi C, Klavinskis LS, Hussain L, Ward RG, Meyers N, Adams SE, Gearing AJ, et al.

J Immunol. 1994 Aug 15;153(4):1858-68.

PMID:
7519218
10.

Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.

Lehner T, Tao L, Panagiotidi C, Klavinskis LS, Brookes R, Hussain L, Meyers N, Adams SE, Gearing AJ, Bergmeier LA.

J Virol. 1994 Mar;68(3):1624-32.

11.

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

Devito C, Zuber B, Schröder U, Benthin R, Okuda K, Broliden K, Wahren B, Hinkula J.

J Immunol. 2004 Dec 1;173(11):7078-89.

12.

Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.

Kato H, Bukawa H, Hagiwara E, Xin KQ, Hamajima K, Kawamoto S, Sugiyama M, Sugiyama M, Noda E, Nishizaki M, Okuda K.

Vaccine. 2000 Jan 18;18(13):1151-60.

PMID:
10649615
13.

Injection of plasmid DNA into the gastric mucosa induces mucosal and systemic immunity.

Sato Y, Saito A, Shishido H, Irisawa A, Miyata M, Obara K, Nishimaki T, Fujita T, Suzuki T, Kasukawa R.

Cell Immunol. 2000 Jan 10;199(1):58-63.

PMID:
10675276
14.
15.

The cellular basis of immune induction at mucosal surfaces by DNA vaccination.

Barnfield C, Brew R, Tilling R, Rae A, Wheeler C, Klavinskis LS.

Dev Biol (Basel). 2000;104:159-64.

PMID:
11713815
16.

M cell DNA vaccination for CTL immunity to HIV.

Wang X, Hone DM, Haddad A, Shata MT, Pascual DW.

J Immunol. 2003 Nov 1;171(9):4717-25.

17.

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J.

J Clin Virol. 2004 Dec;31 Suppl 1:S99-106.

PMID:
15567101
18.

Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.

Kodama S, Hirano T, Noda K, Umemoto S, Suzuki M.

Vaccine. 2011 Feb 24;29(10):1881-90. doi: 10.1016/j.vaccine.2010.12.129. Epub 2011 Jan 13.

PMID:
21237276
19.
20.

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.

Sakaue G, Hiroi T, Nakagawa Y, Someya K, Iwatani K, Sawa Y, Takahashi H, Honda M, Kunisawa J, Kiyono H.

J Immunol. 2003 Jan 1;170(1):495-502.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk